Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University
Articles
Page 1 of 61
-
Citation: Cardiovascular Diabetology 2023 22:246
-
Correction to: Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet‑induced obese rats
An amendment to this paper has been published and can be accessed via the original article.
Citation: Cardiovascular Diabetology 2021 20:53 -
Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
Citation: Cardiovascular Diabetology 2023 22:242 -
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Citation: Cardiovascular Diabetology 2023 22:117 -
Erratum to: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy
Citation: Cardiovascular Diabetology 2013 12:120 -
Correction to: Early impairment of coronary microvascular perfusion capacity in rats on a high fat diet
An amendment to this paper has been published and can be accessed via the original article.
Citation: Cardiovascular Diabetology 2021 20:51 -
Erratum to: CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats
Citation: Cardiovascular Diabetology 2014 13:17 -
Correction to: Diabetes, cardiovascular disease and the microcirculation
An amendment to this paper has been published and can be accessed via the original article.
Citation: Cardiovascular Diabetology 2021 20:120 -
Correction: Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk
Citation: Cardiovascular Diabetology 2022 21:219 -
Professor Alexander Tenenbaum: obituary
Citation: Cardiovascular Diabetology 2022 21:184 -
Correction to: Long‑term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus
An amendment to this paper has been published and can be accessed via the original article.
Citation: Cardiovascular Diabetology 2021 20:31 -
Correction: Prediabetes and all-cause mortality in young patients undergoing coronary artery angiography: a multicenter cohort study in China
Citation: Cardiovascular Diabetology 2023 22:155 -
Erratum to: The metabolic syndrome and progression of carotid atherosclerosis over 13 years: the Tromsø study
Citation: Cardiovascular Diabetology 2013 12:144 -
Correction to: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta‑analysis
Citation: Cardiovascular Diabetology 2021 20:177 -
Correction to: Association between carotid plaque vulnerability and high mobility group box‑1 serum levels in a diabetic population
Citation: Cardiovascular Diabetology 2021 20:184 -
Correction: Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
Citation: Cardiovascular Diabetology 2023 22:116 -
Correction to: Expression of the SARS‑CoV‑2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system
Citation: Cardiovascular Diabetology 2021 20:216 -
Correction: The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors
Citation: Cardiovascular Diabetology 2023 22:127 -
Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes
An amendment to this paper has been published and can be accessed via the original article.
Citation: Cardiovascular Diabetology 2021 20:37 -
Erratum to: Renal denervation in an animal model of diabetes and hypertension: Impact on the autonomic nervous system and nephropathy
Citation: Cardiovascular Diabetology 2011 10:49 -
Correction: Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study
Citation: Cardiovascular Diabetology 2023 22:7 -
The residual cardiorenal risk in type 2 diabetes
In this commentary, we introduce the concepts of removed and residual risks in conditioning thecardiorenal outlook of patients with type 2 diabetes (T2D). The removed cardiorenal risk represents the risk of pr...
Citation: Cardiovascular Diabetology 2021 20:36 -
Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions
The study regarding load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction is very interesting. But there are a few thing...
Citation: Cardiovascular Diabetology 2020 19:29 -
Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
An amendment to this paper has been published and can be accessed via the original article.
Citation: Cardiovascular Diabetology 2021 20:79 -
Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19
A possible association could exist between type 2 diabetes mellitus (T2DM) and Coronavirus-19 (Covid-19) infection. Indeed, patients with T2DM show high prevalence, severity of disease and mortality during Cov...
Citation: Cardiovascular Diabetology 2020 19:76 -
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study
Citation: Cardiovascular Diabetology 2024 23:103 -
Proteasome modulator 9 and macrovascular pathology of T2D
Coronary artery disease (CAD) and stroke share a major linkage at the chromosome 12q24 locus. The same chromosome region entails at least a major risk gene for type 2 diabetes (T2D) within NIDDM2, the non-insu...
Citation: Cardiovascular Diabetology 2011 10:32 -
Correction to: Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet
An amendment to this paper has been published and can be accessed via the original article.
Citation: Cardiovascular Diabetology 2020 19:213 -
Treatment with pioglitazone induced significant, reversible mitral regurgitation
There has in recent years been great concern about possible cardiac side effects of thiazolidinediones (TZDs). We present a case-report of a 60 year-old male who developed significant mitral regurgitation duri...
Citation: Cardiovascular Diabetology 2008 7:12 -
Prediabetes and risk of heart failure: the link grows stronger
In a recently published paper in Cardiovascular Diabetology, Sinha et al. (Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project. Cardiovasc Diabetol. 2021...
Citation: Cardiovascular Diabetology 2021 20:112 -
Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
For years there have been concerns whether the results of large-scale clinical trials that include limited specific patient populations can be applied to patients in real-world clinical practice. Therefore, it...
Citation: Cardiovascular Diabetology 2020 19:132 -
Correction to: Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
An amendment to this paper has been published and can be accessed via the original article.
Citation: Cardiovascular Diabetology 2021 20:61 -
Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy
Recent type 2 diabetes guidance from the UK’s National Institute for Health and Care Excellence (NICE) proposes offering SGLT2-inhibitor therapy to people with established atherosclerotic cardiovascular diseas...
Citation: Cardiovascular Diabetology 2023 22:302 -
Hypercholesterolemia and a candidate gene within the 12q24 locus
The 12q24 locus entails at least one gene responsible for hypercholesterolemia. Within the 12q24 locus lies the gene of proteasome modulator 9 (PSMD9). PSMD9 is in linkage with type 2 diabetes (T2D), T2D-nephropa...
Citation: Cardiovascular Diabetology 2011 10:38 -
Proteasome Modulator 9 SNPs are linked to hypertension in type 2 diabetes families
Chromosome 12q24 was recently associated with hypertension. Proteasome Modulator 9 (PSMD9) lies in the 12q24 locus and is in linkage with MODY3, type 2 diabetes (T2D), microvascular and macrovascular pathology, c...
Citation: Cardiovascular Diabetology 2011 10:77 -
Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
Citation: Cardiovascular Diabetology 2022 21:73 -
How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?
Sodium–glucose cotransporter 2 (SGLT2) inhibitors are increasingly prescribed for the treatment of patients with type 2 diabetes to reduce the risk of cardiovascular events, including heart failure (HF). The m...
Citation: Cardiovascular Diabetology 2020 19:206 -
Cardiovascular guidelines: separate career may help attenuate controversy
The release of recent guidelines for high cholesterol, hypertension and diabetes in the U.S. has been accompanied by great noise and concerns, both in the academic circuits and the lay press. For persons aged ...
Citation: Cardiovascular Diabetology 2014 13:66 -
Correction to: Association between the triglyceride-glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China
Citation: Cardiovascular Diabetology 2023 22:250 -
Treatment strategies in patients with diabetes and three‐vessel coronary disease: What should we choose?
The recent study demonstrating that percutaneous coronary intervention and coronary artery bypass grafting were associated with a lower risk of death and major adverse cardiac and cerebrovascular events (compo...
Citation: Cardiovascular Diabetology 2021 20:42 -
Correction: Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells
Citation: Cardiovascular Diabetology 2023 22:229 -
Correction: Dapaglifozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling
Citation: Cardiovascular Diabetology 2022 21:224 -
Role of obesity and hypertension in the incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
In a cohort study performed using primary care databases in a General Practitioners Network, Groenewegen et al. report a clear association between diabetes and incidence of the major chronic progressive heart ...
Citation: Cardiovascular Diabetology 2021 20:162 -
Correction: Comparison of 2‑year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry
Citation: Cardiovascular Diabetology 2023 22:159 -
Correction: Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials
Citation: Cardiovascular Diabetology 2023 22:95 -
Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes
Citation: Cardiovascular Diabetology 2024 23:74 -
Correction: CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
Citation: Cardiovascular Diabetology 2023 22:196 -
Correction: Higher HbA1c variability is associated with increased arterial stiffness in individuals with type 1 diabetes
Citation: Cardiovascular Diabetology 2023 22:83 -
Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?
Citation: Cardiovascular Diabetology 2020 19:141 -
Ethnicity should be included as a risk factor for coronary artery calcium score
Coronary artery calcium score (CACs) is a measurement of calcification in coronary arteries using a computed tomography scan. It has a predictive role for future myocardial infarction thus it aids in cardiovas...
Citation: Cardiovascular Diabetology 2022 21:150
Annual Journal Metrics
-
2022 Citation Impact
9.3 - 2-year Impact Factor
9.6 - 5-year Impact Factor
2.054 - SNIP (Source Normalized Impact per Paper)
2.361 - SJR (SCImago Journal Rank)2023 Speed
4 days submission to first editorial decision for all manuscripts (Median)
56 days submission to accept (Median)2023 Usage
2,523,778 downloads
3,115 Altmetric mentions